DCGI Seek Serum Institute Of India Clarification On Oxford COVID-19 Vaccine Trials

Serum Institute of India (SII) has been asked to revise its protocol
for the COVID-19 vaccine trial by a CDSCO panel after they submitted
an application to Drugs Controller General of India (DCGI) requesting
permission for conducting phase 2 and 3 human clinical trials of the
candidate COVID-19 vaccine by Oxford University. A meeting of […]

The post DCGI Seek Serum Institute Of India Clarification On Oxford
COVID-19 Vaccine Trials appeared first on BioTecNika .

https://www.biotecnika.org/2020/07/oxford-vaccine-trial-in-india-dcgi-seek-sii-further-clarification/

Biotech News

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Biotecnika Times Newsletter 29.11.2021 NABI Research Training, National Cancer Tissue

Biotecnika Times – Newsletter 25.01.2021 – CSIR Notice, CSIR-CCMB & ILS Hiring, FSSAI Funded